SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 3, 2026

CYTK

CYTOKINETICS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed13d 5h ago
Insider cluster: 2 insiders, $691K total
Actionable Insight • Neutral

Sales are pre-planned and trivial in size. No read-through for fundamentals. Monitor next quarterly filing for any change in insider ownership patterns.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$63.60
T+0 close · Nov 3, 2026 · via day close
Latest settled
−7.97%
T+5 · $58.53 · next T+20 in 16d
Vs SPY
−7.06%
α at T+5
Latest observation
−12.20%
T+7 · FF3 residual α
  1. T+0 · Nov 4 $63.60entry
  2. T+1 · 12d ago −12.66%α −8.25% · $55.55
  3. T+5 · 6d ago −7.97%α −7.06% · $58.53
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO and EVP of R&D sold shares under 10b5-1 plans for total proceeds of $691K, representing less than 0.01% of market cap. Both sales are routine and immaterial relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$691.0K
Insiders
2

Key Facts

  • CEO Robert Blum sold 7,500 shares at $62.81 for $471K on Nov 2
  • EVP R&D Fady Malik sold 3,500 shares at $62.93 for $220K on Nov 3
  • Both sales were executed under 10b5-1 trading plans
  • Total proceeds of $691K represent less than 0.01% of $8.8B market cap
  • Sales followed derivative exercises at nominal cost

Financial Impact

$691K total insider sales, negligible relative to $8.8B market cap

Risk Factors

  • Insider sales are routine and immaterial; no elevated risk identified

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (28 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYTK-1793741928556

Track record

46 reports on CYTK

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $53.17 −1.10% settles Dec 15
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $53.17 −5.27% settles Dec 14
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
  4. Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
  5. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
  6. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
  7. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  8. Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $53.17 −4.28% settles Dec 4
  9. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Viewing Entry $63.60 Now $53.17 −16.40% settles Dec 3
  10. Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $53.17 −14.28% settles Dec 1
Showing 10 of 46

US Market Status

Market Closed · Opens Wed (10h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026